Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

6.37USD
23 Apr 2018
Change (% chg)

$0.25 (+4.08%)
Prev Close
$6.12
Open
$6.12
Day's High
$6.45
Day's Low
$6.12
Volume
8,719
Avg. Vol
55,255
52-wk High
$15.78
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $8.74
Shares Outstanding(Mil.): 1.43
Dividend: --
Yield (%): --

Financials

  TENX.OQ Industry Sector
P/E (TTM): -- 185.04 32.78
EPS (TTM): -6.27 -- --
ROI: -67.94 -0.74 13.21
ROE: -67.94 -2.80 15.01

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

Jan 16 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF76.04 -0.04
Merck & Co., Inc. (MRK.N) $60.25 +1.42
Roche Holding Ltd. (ROG.S) CHF217.60 +1.95
Roche Holding Ltd. (RO.S) CHF221.40 +1.40
Abbott Laboratories (ABT.N) $58.84 -0.35
Bayer AG (BAYGn.DE) €98.79 -0.21
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €65.71 +0.43
Eli Lilly And Co (LLY.N) $80.20 +1.14
Bristol-Myers Squibb Co (BMY.N) $50.90 -0.27

Earnings vs. Estimates